Back
Snap, Inc. Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison
Sell
45
SNAP
Snap, Inc.
Last Price:
$7.98
Seasonality Move:
4.17%
Buy
86
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$43.42
Seasonality Move:
10.06%
Sell
45
Snap, Inc. (SNAP)
is a Sell
Is Snap, Inc. a Buy, Sell or Hold?
-
The current Snap, Inc. [SNAP] share price is $7.91. The Score for SNAP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
SNAP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
86
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $48.92. The Score for RIGL is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SNAP Stock Price Chart
What is Snap, Inc.'s stock price today?
-
The Snap, Inc. share price today is $7.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNAP is experiencing slight buying pressure.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $48.92The current trend is moderately bearish and RIGL is experiencing slight buying pressure.
SNAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 50.5 | Buy |
| Chaikin Money Flow: | 13441229 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.53 - 8.43) | Sell |
| Bollinger Bands (100): | (7.22 - 8.84) | Sell |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.77 | Buy |
| Relative Strength Index (14 RSI): | 63.6 | Buy |
| Chaikin Money Flow: | 135148 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.54 - 48.5) | Buy |
| Bollinger Bands (100): | (25.79 - 42.07) | Buy |
SNAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.69 | Buy |
| 20-day SMA: | 8.05 | Sell |
| 50-day SMA: | 7.98 | Sell |
| 200-day SMA: | 8.37 | Sell |
| 8-day EMA: | 7.77 | Buy |
| 20-day EMA: | 7.86 | Buy |
| 50-day EMA: | 7.94 | Sell |
| 200-day EMA: | 8.64 | Sell |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.27 | Buy |
| 20-day SMA: | 44.3 | Buy |
| 50-day SMA: | 35.46 | Buy |
| 200-day SMA: | 26.64 | Buy |
| 8-day EMA: | 47.4 | Buy |
| 20-day EMA: | 44.2 | Buy |
| 50-day EMA: | 38.75 | Buy |
| 200-day EMA: | 29.05 | Buy |
Snap, Inc. Earnings Growth & SNAP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.15 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.08 per share, and a decrease next year of $2.30 per share.
Snap, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||